Brought to you by:
Cracking CLTI: How Shockwave Javelin intravascular lithotripsy is opening up new frontiers in heavily calcified peripheral arterial occlusive disease
This advertorial is sponsored by Shockwave Medical. Three vascular surgeons discuss how and when they deploy the transformative Shockwave Javelin first-of-its-kind Forward Intravascular Lithotripsy (IVL) Platform in cases of heavily calcified peripheral vascular occlusive disease. Viewpoints on when and how…
Shockwave Medical announces US launch of intravascular lithotripsy catheter
Today, Shockwave Medical announced the U.S. launch of its Shockwave Javelin peripheral intravascular lithotripsy (IVL) catheter, a platform designed to modify calcium and cross narrowed vessels in patients with peripheral artery disease (PAD). The platform is designed to modify calcium…
Incorporation of Shockwave E8 Peripheral IVL into the treatment of patients with chronic limb-threatening ischemia
This advertorial is sponsored by Shockwave Medical. Anand Prasad, MD, an 18-year veteran of vascular and endovascular medicine with a particular interest in peripheral arterial disease (PAD) in patients with chronic kidney disease (CKD), explores the deliverability of the Shockwave…
Shockwave Javelin peripheral IVL catheter meets prespecified efficacy and safety performance goals in feasibility and IDE studies
Shockwave Medical, part of Johnson & Johnson MedTech, has announced the first clinical outcomes associated with the Shockwave Javelin peripheral intravascular lithotripsy (IVL) catheter, a novel, non-balloon-based lithotripsy platform designed to modify calcium and cross extremely narrowed vessels in patients…
The Shockwave E8 experience: Featuring the new Shockwave peripheral IVL workhorse
This advertorial is sponsored by Shockwave Medical. Paul J. Foley III, MD, a vascular surgeon and director of the non-invasive vascular lab at Doylestown Hospital in Doylestown, Pennsylvania, and adjunct associate professor of surgery at the University of Pennsylvania in…
Shockwave Medical expands US peripheral IVL portfolio with enhanced catheter
Shockwave Medical, part of Johnson & Johnson MedTech, has announced the full U.S. launch of its Shockwave E8 peripheral intravascular lithotripsy (IVL) catheter, following clearance by the Food and Drug Administration (FDA). A company press release details that the Shockwave…
Shockwave L6 catheter expands treatment options for large-vessel cases
Shockwave L6 catheter achieves ‘almost pristine’ result in challenging case
Adding 8–12mm diameter devices to the Shockwave Peripheral Intravascular Lithotripsy toolkit
This advertorial is sponsored by Shockwave Medical. Mazin Foteh, MD, contrasts the benefits of Shockwave Medical’s new Shockwave L6 Peripheral Intravascular Lithotripsy Catheter alongside those of its sister device, the Shockwave M5+ Peripheral Intravascular Lithotripsy Catheter. The Shockwave L6 device…
Shockwave Medical announces US launch of new peripheral IVL catheter
Shockwave Medical announced the full U.S. commercial availability of the Shockwave L6 peripheral intravascular lithotripsy (IVL) catheter following clearance by the Food and Drug Administration (FDA). A press release details that the Shockwave L6 catheter is purpose-built to modify calcification in otherwise difficult-to-treat…